J8498 – Antiemetic drug, rectal/suppository, not otherwise specified

Long description

Antiemetic drug, rectal/suppository, not otherwise specified

Short description

Antiemetic rectal/supp nos

Pricing indicator

51 Drugs

Medicare coverage

D Special coverage instructions apply

BETOS category

O1D Chemotherapy

Added

January 1, 2006

Last change

January 1, 2006 – No change

Nearby J codes

• J7682 – Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams
• J7683 – Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
• J7684 – Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
• J7685 – Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams
• J7686 – Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg
• J7699 – Noc drugs, inhalation solution administered through dme
• J7799 – Noc drugs, other than inhalation drugs, administered through dme
• J7999 – Compounded drug, not otherwise classified
• J8499 – Prescription drug, oral, non chemotherapeutic, nos
• J8501 – Aprepitant, oral, 5 mg
• J8502 – Injection, aprepitant (aponvie), 1 mg
• J8510 – Busulfan; oral, 2 mg
• J8515 – Cabergoline, oral, 0.25 mg
• J8520 – Capecitabine, oral, 150 mg
• J8521 – Capecitabine, oral, 500 mg
• J8522 – Capecitabine, oral, 50 mg